IRB Advisor – May 1, 2017
May 1, 2017
View Issues
-
NIH Ethics Panel Vetoes Zika Human Infection Trials
While there are reports of various Zika vaccine trials proceeding, one the most promising methods to quickly and accurately measure vaccine efficacy has come to a full stop.
-
Researcher: Human Infection Trials for Zika Could Be Safely Performed
It sounds counterintuitive, but one of the main arguments for getting a Zika virus vaccine into human trials is that as susceptible people become immune through prior infection, it will be harder to test vaccine efficacy in a large population.
-
IRB Has Variety of Self-Assessment, Staff Assessment Tools
An Indiana research compliance program found that IRB staff and board assessments help keep the program on track and running well.
-
Creating an Optimal Research Training and Mentoring Program
A nine-year IRB chair veteran and a medical school’s associate dean identified gaps in their institution’s human research protection education. They noticed that online training was fine for general information, but came up short when investigators were struggling with specific protocol issues.
-
Conduct a QA/QI Research Program Risk Assessment
Human research protection programs (HRPPs) are required to assess their quality, efficiency, and effectiveness if they’re seeking accreditation. HRPPs can do this through ongoing quality assurance/quality improvement (QA/QI) programs. But sometimes the quality improvement program also needs to be assessed for quality.